Page 6 - Mci News Today

SINGAPORE — Despite years of advocacy and action to protect children from online harms, the percentage of children exposed to online harms worldwide continues to hover at around 70 per cent on average each year for seven years.

Cardiovascular risk factors and multi-comorbidity appear to play an important role in the association between atrial fibrillation and mild cognitive impairment.

Data from a small phase I study show significant clinical and biomarker activity of an investigational natural killer cell therapy in adults with AD, prompting a larger phase 2 trial.

Minnova Corp. (CVE:MCI – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.02 and last traded at C$0.03, with a volume of 85000 shares traded. The stock had previously closed at C$0.03. Minnova Price Performance The company has a debt-to-equity ratio of […]

A US study has revealed major gaps in the detection of mild cognitive impairment in primary care, with the vast majority of older adults with the condition undiagnosed.

New data from TRAILBLAZER-ALZ 2 show robust amyloid clearance with donanemab in APOE4 carriers and noncarriers, mitigating the risk of disease progression and dependency.

Mothership broke an embargo in September about an increase in water prices.

Plasma MTBR-tau243 reflects changes in tau pathology and can be used to stage AD tauopathy and to determine if cognitive symptoms are likely due to AD pathology.

An investigational dual PPAR agonist modifies Alzheimers pathology and shows cognitive benefit in adults with mild-to-moderate disease and high plasma pTau-217 ratio, early data show.

Ultraprocessed foods, which account for about 60% of the American diet, are tied to cancer, diabetes, and heart disease. Now, a growing body of research suggests they also negatively affect the brain.